Scientific Program
|
Friday, March 3, 2017 |
||
|
09:00 |
Registration and Distribution of Materials |
|
|
11:30-13:00 |
RIETE/SEMI SYMPOSIUM |
|
|
14:00 |
Opening Remarks Symposium Chairmen Ian A. Greer, UK; Benjamin Brenner, Israel; Manuel Monreal, Spain |
|
|
14:10-15:45 |
SESSION 1: Cancer and Thrombosis in Women |
|
|
14:10 |
Thrombosis, cancer and women’s health: Lessons from RIETE Manuel Monreal, Spain |
|
|
14:35 |
Role of heparanase in cancer and thrombosis Yona Nadir, Israel |
|
|
15:00 |
Update on antithrombotic management guidelines Dominique Farge-Bancel, France |
|
|
15:25 |
Selected Oral Communications |
|
|
15:45 – 16:15 |
Coffee Break & Exhibition Visit |
|
|
16:15 – 18:00 |
SESSION 2: Pregnancy Complications |
|
|
16:15 |
Placental hemostasis and sterile inflammation: New insights into placental vascular disease Berend Isermann, Germany |
|
|
16:40 |
Antiphospholipid antibodies and the risk of pregnancy complications Jean-Christophe Gris, France |
|
|
17:05 |
Anticoagulants to prevent recurrent placenta mediated pregnancy complications: Is it time to put the needles away? Marc A. Rodger, Canada |
|
|
17:30 |
Selected Oral Communications |
|
|
20:00 - 22:00 |
GET TOGETHER RECEPTION |
|
Saturday, March 4, 2017 |
||
|
08:30 – 10:15 |
SESSION 3: Arterial Thrombosis |
|
|
08:30 |
Atherosclerosis, inflammation and coagulation Lina Badimon, Spain |
|
|
08:55 |
Antiphospholipid syndrome Ricardo Cervera, Spain |
|
|
09:20 |
Managing long-term oral anticoagulation in women Michael Nagler, Switzerland |
|
|
09:45 |
Selected Oral Communications |
|
|
10:15 – 10:45 |
Coffee Break & Exhibition Visit |
|
|
10:45 – 12:30 |
SESSION 4: Systemic Syndromes |
|
|
10:45 |
Impact of haemostatic mechanisms on pathophysiology of preeclampsia Chris Gardiner, UK |
|
|
11:10 |
Effect of BMI on hemostasis: Implications for thrombosis in women’s health Beverly J. Hunt, UK |
|
|
11:35 |
DIC score in pregnant women Ofer Erez, Israel |
|
|
12:00 |
Selected Oral Communications |
|
|
12:30-13:30 |
LUNCH |
|
|
13:30 – 15:15 |
SESSION 5: Acute Coronary Syndromes and Hormonal Impacts on Hemostasis |
|
|
13:30 |
Prevention and management of ovarian hyperstimulation syndrome Scott M. Nelson, UK |
|
|
13:55 |
LMWH use in IVF - Biomarkers and benefits Simon Fishel, UK |
|
|
14:20 |
Does ART influence the use of thromboprophylaxis in pregnancy? Elvira Grandone, Italy |
|
|
14:45 |
Selected Oral Communications |
|
|
15:15 – 15:45 |
Coffee Break & Exhibition Visit |
|
|
16:45 – 18:00 |
Poster Session |
|
|
20:00 |
FAREWELL DINNER (optional) |
|
|
Sunday, March 5, 2017 |
||
|
09:00 – 10:45 |
SESSION 6: Bleeding Disorders |
|
|
09:00 |
Menorrhagia - Update on management Rezan Abdul-Kadir, UK |
|
|
09:25 |
Liver disease in pregnancy Ton Lisman, the Netherlands |
|
|
09:50 |
Acquired hemophilia Gili Kenet, Israel |
|
|
10:15 |
Selected Oral Communications |
|
|
10:45 – 11:15 |
Coffee Break & Exhibition Visit |
|
|
11:15 – 13:00 |
SESSION 7: Venous Thromboembolism in Women |
|
|
11:15 |
The influence of family history and thrombophilia on risk of gestational VTE Rainer Zotz, Germany |
|
|
11:40 |
Pitfalls in the diagnosis of pulmonary embolism in pregnancy Liselotte van der Pol, the Netherlands |
|
|
12:05 |
Risk-adapted management of pulmonary embolism Stavros V. Konstantinides, Germany |
|
|
12:30 |
Selected Oral Communications |
|
|
13:00 – 14:00 |
LUNCH |
|
|
14:00 – 15:45 |
SESSION 8: Peri-partum and Neonatal Complications |
|
|
14:00 |
Immune thrombocytopenia in pregnancy Sue Pavord, UK |
|
|
14:25 |
Neonatal thrombosis Monika Stoll, Germany |
|
|
14:50 |
Allo-immune thrombocytopenia Lilach Bonstein, Israel |
|
|
15:15 |
Selected Oral Communications |
|
|
15:45 |
Concluding Remarks – Symposium Chairmen |
|
